Smad2 Phosphorylation in Diabetic Kidney Tubule Epithelial Cells Is Associated with Modulation of Several Transforming Growth Factor-β Family Members

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nephron

• Publication date

  2017-01-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000453337PMID 28064277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• BAMBI Elimination Enhances Alternative TGF-β Signaling and Glomerular Dysfunction in Diabetic Mice

  2015cited by this paper
• Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.

  2015cited by this paper
• Gremlin1 preferentially binds to bone morphogenetic protein-2 (BMP-2) and BMP-4 over BMP-7.

  2015cited by this paper
• Autosomal dominant polycystic kidney disease.

  2014cited by this paper
• Recent Advances in Animal Models of Diabetic Nephropathy

  2014cited by this paper
• Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression

  2014cited by this paper
• Gremlin aggravates hyperglycemia‐induced podocyte injury by a TGFβ/smad dependent signaling pathway

  2013cited by this paper
• Circulating sclerostin levels and bone turnover in type 1 and type 2 diabetes.

  2012cited by this paper
• Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?

  2012cited by this paper
• Diverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation

  2011cited by this paper
• Transforming growth factor-β and Smads.

  2011cited by this paper
• Diabetic kidney disease with and without albuminuria

  2011cited by this paper
• BMP-6 emerges as a potential major regulator of fibrosis in the kidney.

  2011cited by this paper
• Loss of endogenous bone morphogenetic protein-6 aggravates renal fibrosis.

  2011cited by this paper
• Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.

  2010cited by this paper
• Smad2 Positively Regulates the Generation of Th17 Cells*

  2010cited by this paper
• Smad2 protects against TGF-beta/Smad3-mediated renal fibrosis.

  2010cited by this paper
• Pathologic classification of diabetic nephropathy.

  2010cited by this paper
• Effect of activin A on tubulointerstitial fibrosis in diabetic nephropathy

  2009cited by this paper
• Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression

  2008cited by this paper
• Glucocorticoids activate TGF-β induced PAI-1 and CTGF expression in rat hepatocytes

  2007cited by this paper
• Tubular changes in obstructed kidney of adult mice evaluated using immunohistochemistry for segment-specific marker.

  2007cited by this paper
• Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.

  2006cited by this paper
• Plasminogen activator inhibitor-1 in chronic kidney disease: evidence and mechanisms of action.

  2006cited by this paper
• The Cysteine-Rich Domain Protein KCP Is a Suppressor of Transforming Growth Factor β/Activin Signaling in Renal Epithelia

  2006cited by this paper
• Plasminogen activator inhibitor‐1 and diabetic nephropathy

  2005cited by this paper
• BMP4 substitutes for loss of BMP7 during kidney development.

  2005cited by this paper
• Activation of STAT3/Smad1 Is a Key Signaling Pathway for Progression to Glomerulosclerosis in Experimental Glomerulonephritis*

  2005cited by this paper
• Activins and Inhibins and Their Signaling

  2004cited by this paper
• The health care costs of diabetic nephropathy in the United States and the United Kingdom.

  2004cited by this paper
• Macrophages in streptozotocin-induced diabetic nephropathy: potential role in renal fibrosis.

  2004cited by this paper
• Type IV Collagen Is Transcriptionally Regulated by Smad1 under Advanced Glycation End Product (AGE) Stimulation*

  2004cited by this paper
• Bone morphogenetic protein-7 signals opposing transforming growth factor beta in mesangial cells.

  2004cited by this paper
• Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.

  2004cited by this paper
• Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction

  2004cited by this paper
• Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease

  2004cited by this paper
• Bone Morphogenetic Protein-7 Signals Opposing Transforming Growth Factor β in Mesangial Cells*

  2004cited by this paper
• BMP-7 counteracts TGF-β1–induced epithelial-to-mesenchymal transition and reverses chronic renal injury

  2003cited by this paper
• Bone morphogenic protein-7 (BMP-7), a novel therapy for diabetic nephropathy.

  2003cited by this paper
• TGF-beta isoforms in renal fibrogenesis.

  2003cited by this paper
• TGF-β isoforms in renal fibrogenesis

  2003cited by this paper
• Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

  2002cited by this paper
• SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7.

  2002cited by this paper
• Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

  2001cited by this paper
• Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy.

  2001cited by this paper
• Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation.

  2001cited by this paper
• Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury.

  2000cited by this paper
• Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

  1999cited by this paper
• Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair

  1999cited by this paper
• Characterization of bone morphogenetic protein-6 signaling pathways in osteoblast differentiation.

  1999cited by this paper
• Acute and chronic renal effects of recombinant human TGF-beta2 in the rat.

  1999cited by this paper
• Acute and Chronic Renal Effects of Recombinant Human TGF-β2 in the Rat

  1999cited by this paper
• Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats1

  1998cited by this paper
• Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition.

  1998cited by this paper
• Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic rats.

  1998cited by this paper
• The L45 loop in type I receptors for TGF‐β family members is a critical determinant in specifying Smad isoform activation

  1998cited by this paper
• Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes.

  1997cited by this paper
• TGF‐β receptor‐mediated signalling through Smad2, Smad3 and Smad4

  1997cited by this paper
• Erratum: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes (Diabetes (1997) 46 (473- 480))

  1997cited by this paper
• TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

  1997cited by this paper
• Effects of activin A on proliferation and differentiation of human lung fibroblasts.

  1996cited by this paper
• Neutralization of TGF-β by Anti-TGF-β Antibody Attenuates Kidney Hypertrophy and the Enhanced Extracellular Matrix Gene Expression in STZ-Induced Diabetic Mice

  1996cited by this paper
• Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats.

  1996cited by this paper
• [The renal tubulointerstitium in diabetes mellitus].

  1995cited by this paper
• Unchanged Incidence of Diabetic Nephropathy in IDDM Patients

  1995cited by this paper
• BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning.

  1995cited by this paper
• The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms.

  1994cited by this paper
• Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

  1994cited by this paper
• Renal hypertrophy is associated with upregulation of TGF-beta 1 gene expression in diabetic BB rat and NOD mouse.

  1994cited by this paper
• Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

  1993cited by this paper
• Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy.

  1993cited by this paper
• Autosomal dominant polycystic kidney disease.

  1993cited by this paper
• The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis.

  1991cited by this paper
• The renal tubulointerstitium in diabetes mellitus.

  1991cited by this paper

• Emerging role of hsa_circ_0000652, hsa-miR-21, SMAD2, and Foxo1 in type 2 diabetes mellitus pathogenesis

  2025cites this paper
• ADAM17 promotes colorectal cancer migration and invasion by regulating the TGF-β/Smad signaling pathway.

  2024cites this paper
• Bone health in young adults with type 1 diabetes and progressive eGFR decline

  2024cites this paper
• Protective Effect of Silent Mating Type Information Regulation 2 Homolog 1 on TGF-<i>β</i>1 Pathway via mTOR in Diabetic Nephropathy

  2023cites this paper
• Ponicidin attenuates streptozotocin‐induced diabetic nephropathy in rats via modulating hyperlipidemia, oxidative stress, and inflammatory markers

  2022cites this paper
• Renal fibrosis as a hallmark of diabetic kidney disease: potential role of targeting transforming growth factor-beta (TGF-β) and related molecules

  2022cites this paper
• The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation

  2022cites this paper
• Buyang Huanwu Decoction protects against STZ-induced diabetic nephropathy by inhibiting TGF-β/Smad3 signaling-mediated renal fibrosis and inflammation

  2021cites this paper
• Salidroside from Rhodiola rosea L. attenuates diabetic nephropathy in STZ induced diabetic rats via anti-oxidative stress, anti-inflammation, and inhibiting TGF-β1/Smad pathway

  2021cites this paper
• An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy

  2021cites this paper
• Assessing and Counteracting Fibrosis is a Cornerstone of the Treatment of CKD Secondary to Systemic and Renal Limited Autoimmune Disorders.

  2021cites this paper
• Transforming Growth Factor-Beta1 in Diabetic Kidney Disease

  2020cites this paper
• In-silico investigations of selective miRNA-gene targets and their validation studies in obstructive sleep apnea (OSA) patient cohorts

  2020cites this paper
• Microparticles as Potential Mediators of High Glucose-Induced Renal Cell Injury

  2019cites this paper
• Urine mitochondrial DNA and diabetic nephropathy-a new frontier.

  2018cites this paper
• Dicer deficiency in proximal tubules exacerbates renal injury and tubulointerstitial fibrosis and upregulates Smad2/3.

  2018cites this paper
• MiR‐130b increases fibrosis of HMC cells by regulating the TGF‐β1 pathway in diabetic nephropathy

  2018cites this paper
• Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium

  2017cites this paper